SCHEMBL7701986

SCHEMBL7701986

CCCc1[nH]c2cc(C(=O)NCc3ccccc3Cl)ccc2c1C(C)=NO

nearest known ligand 0.54

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ROCK2 O75116 6/20 0.54
SMN1; SMN2 Q16637 5/20 0.51
CASP6 P55212 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.47
POLB P06746 1/20 0.45
MAPK1 P28482 2/20 0.44
MAPK3 P27361 1/20 0.44
LMNA P02545 2/20 0.44
TP53 P04637 1/20 0.44
KDM4E B2RXH2 1/20 0.44
MAPT P10636 1/20 0.43
ALDH1A1 P00352 2/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
PKM P14618 1/20 0.42
HTT P42858 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7707825 0.91 ROCK2 (0.57) ROCK2SMN1; SMN2CASP6L3MBTL1POLB
SCHEMBL8554376 0.88 ROCK2 (0.56) ROCK2SMN1; SMN2CASP6L3MBTL1POLB
SCHEMBL18073895 0.87 ROCK2 (0.56) ROCK2SMN1; SMN2CASP6L3MBTL1POLB
SCHEMBL8556812 0.85 ROCK2 (0.60) ROCK2SMN1; SMN2CASP6L3MBTL1POLB
SCHEMBL8555167 0.78 ROCK2 (0.63) ROCK2SMN1; SMN2CASP6POLBMAPK1
SCHEMBL8551666 0.75 KDM4E (0.45) ROCK2SMN1; SMN2LMNAKDM4EMAPT
SCHEMBL8555308 0.75 ROCK2 (0.62) ROCK2SMN1; SMN2CASP6L3MBTL1MAPK1
SCHEMBL8556569 0.74 ROCK2 (0.63) ROCK2SMN1; SMN2CASP6L3MBTL1MAPK1
SCHEMBL8629096 0.74 MAPT (0.55) POLBLMNAKDM4EMAPTALDH1A1
SCHEMBL8555953 0.74 ROCK2 (0.56) ROCK2SMN1; SMN2CASP6L3MBTL1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6358992-B1 Method of inhibiting neoplastic cells with indole derivatives CELL PATHWAYS, INC. 2002-03-19 US disclosed